Loading
AP
Acasti Pharma Inc. Stock: price and insider trades · Canada
Acasti Pharma Inc.: what insiders have been doing
This page follows insider dealings at Acasti Pharma Inc. as filed with SEDI. No insider at Acasti Pharma Inc. has published a filing in the past twelve months. The most recent one dates from 17 October 2023.
Our records for Acasti Pharma Inc. go back to 2016, with 17 purchases and 19 sales on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
74
Thresholds
n/a
Buy Volume
€519,919
17 ops. · all time
Sell Volume
€377,067
19 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 17 October 2023
Declarations74 total
Common Shares (Actions de catégorie A)TSXSEDI:4198138
Common Shares (Actions de catégorie A)TSXSEDI:4197776
Common Shares (Actions de catégorie A)TSXSEDI:4197775
676,371 shares@ CA$1.8481Common Shares (Actions de catégorie A)TSXSEDI:4187951
Common Shares (Actions de catégorie A)TSXSEDI:4178324
381 shares@ CA$2.05Common Shares (Actions de catégorie A)TSXSEDI:4178382
Canonical exit: 29 Nov 2023 (T+90)
792 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158989
128,138 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158984
11,119 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158965
511,705 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158980
4,689,547 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158972
66,712 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158963
746,064 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158977
3,070,229 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158979
21,357 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158985
781,592 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158974
38,000 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158988
124,344 sharesCommon Shares (Actions de catégorie A)TSXSEDI:4158978
Common Shares (Actions de catégorie A)TSXSEDI:4129201
Common Shares (Actions de catégorie A)TSXSEDI:4001629
10,600 shares@ CA$2.72100.0% of flowCommon Shares (Actions de catégorie A)TSXSEDI:3430212
Canonical exit: 25 Dec 2019 (T+90)
Common Shares (Actions de catégorie A)TSXSEDI:3430210
1,600 shares@ CA$1.8852.0% of flowCommon Shares (Actions de catégorie A)TSXSEDI:3412633
Canonical exit: 17 Nov 2019 (T+90)
8,400 shares@ CA$1.8910.6% of flowCommon Shares (Actions de catégorie A)TSXSEDI:3412632
Canonical exit: 17 Nov 2019 (T+90)
38,000 shares@ CA$1.28100.0% of flowCommon Shares (Actions de catégorie A)TSXSEDI:3254530
Canonical exit: 21 Jan 2019 (T+90)
25 of 74 declarations
About Acasti Pharma Inc.
Acasti Pharma Inc. is a biopharmaceutical company focused on developing treatments for cardiovascular diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.
